A review of disease burden and clinical management for generalized pustular psoriasis in China-Reference-Cited by-同舟云学术

A review of disease burden and clinical management for generalized pustular psoriasis in China

Published:2022-09-07 Issue:10 Volume:18 Page:1023-1032
ISSN:1744-666X
Container-title:Expert Review of Clinical Immunology
language:en
Short-container-title:Expert Review of Clinical Immunology

Author:

Lu Jiajing¹,Shi Yuling¹²

Affiliation:

1. Department of Dermatology, Shanghai Skin Disease Hospital, School of Medicine, Tongji University, Shanghai, Tongji, China

2. Department of Dermatology, Institute of Psoriasis, School of Medicine, Tongji University, Shanghai, Tongji, China

Funder

National Natural Science Foundation of China

Innovation Programme of Shanghai Municipal Education Commission

Clinical Research Plan of SHDC

Programme of Shanghai Academic Research Leader

Program of Science and Technology Commission of Shanghai Municipality

Excellent Subject Leader Programme of Shanghai Municipal Commission of Health and Family Planning

Publisher

Informa UK Limited

Subject

Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/1744666X.2022.2118716

Reference79 articles.

1. Pustular Psoriasis: The Dawn of a New Era

2. An update on generalized pustular psoriasis

3. Feng Q, Guo J, Zhang Q, et al. Evaluation of prevalence and disease burden of generalized pustular psoriasis in China: based on data (2012-2016) from the national health insurance database. unpublished. 2021

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Epidemiology and distribution of 207 rare diseases in China: A systematic literature review;Intractable & Rare Diseases Research;2024-05-31

2. Tobacco smoking negatively influences the achievement of greater than three-quarters reduction in psoriasis area and severity index after eight weeks of treatment among patients with psoriasis: Findings from a prospective study;Tobacco Induced Diseases;2024-04-11

3. Acquired diffuse palmoplantar erythema with keratoderma in Chinese patients with pustular psoriasis: A predictor for IL36 receptor antagonist c.115+6T>C mutation?;Experimental Dermatology;2024-03

4. Clinical and Disease Burden of Patients with Generalized Pustular Psoriasis: A Review of Real-World Evidence;Dermatology and Therapy;2024-02

5. Better efficacy, lower recurrence rate and decreased CD8+TRM with guselkumab treatment for generalized pustular psoriasis: A prospective cohort study from China;Clinical Immunology;2024-02